Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-28T16:03:11.021Z Has data issue: false hasContentIssue false

The use of clozapine

Published online by Cambridge University Press:  02 January 2018

Amir H. Kalali
Affiliation:
University of California at Irvine, UCIMC, Building 3, Rt. 88, 101 The City Drive South, Orange, CA 92668, USA
Steven G. Potkin
Affiliation:
University of California at Irvine, UCIMC, Building 3, Rt. 88, 101 The City Drive South, Orange, CA 92668, USA
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1995

References

Kronig, , et al (1995) Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients. American Journal of Psychiatry, 152, 179182.Google Scholar
Miller, D. D., et al (1994) Plasma clozapine concentration as a predictor of clinical response: A follow-up study. Journal of Clinical Psychiatry, 56(9, suppl. B), 177–121.Google Scholar
Potkin, S. G., et al (1994) Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. Journal of Clinical Psychiatry, 55(9, suppl. B), 133136.Google Scholar

A correction has been issued for this article:

Submit a response

eLetters

No eLetters have been published for this article.